Cardiovascular Effects of Metformin
Type 2 diabetes mellitus is one of the most important independent risk factors for the development, progression and mortality from cardiovascular diseases (CVD). The world communities are faced with the question of developing the optimal management tactics for such comorbidity patients. Thus, the pr...
Saved in:
Main Authors: | B. T. Kurmanbekova (Author), A. M. Noruizbaeva (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin
by: Malcolm J. Borg, et al.
Published: (2020) -
Risk of antidepressant initiation among users of cardiovascular agents and metformin.
by: Ivana Bojanić, et al.
Published: (2023) -
Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia
by: Wiebe M. C. Top, et al.
Published: (2022) -
Metformin adherence and the risk of cardiovascular disease: a population-based cohort study
by: Shun-Fan Yu, et al.
Published: (2023) -
Effect of Total Amount of Metformin HCl on the Characteristics of Metformin-Ca Alginate Microspheres
by: Dewi Melani Hariyadi, et al.
Published: (2019)